Magnolicomb HCT 5 mg/160 mg/25 mg filmom obložene tablete
| Name | Magnolicomb HCT 5 mg/160 mg/25 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-095154612 |
| Active Substance | amlodipinbesilat valsartan hidroklorotiazid |
| Composition | svaka filmom obložena tableta sadrži 5 mg amlodipina (u obliku amlodipinbesilata), 160 mg valsartana i 25 mg hidroklorotiazida |
| Pharmaceutical Form | filmom obložena tableta |
| Packaging [MA Number for Packaging] | 14 tableta u blisteru, u kutiji [HR-H-095154612-01] 28 tableta u blisteru, u kutiji [HR-H-095154612-02] 30 tableta u blisteru, u kutiji [HR-H-095154612-03] 56 tableta u blisteru, u kutiji [HR-H-095154612-04] 90 tableta u blisteru, u kutiji [HR-H-095154612-05] 98 tableta u blisteru, u kutiji [HR-H-095154612-06] |
| Manufacturer | Genepharm S.A., Pallini, Attiki, Grčka Jadran Galenski laboratorij d.d., Rijeka, Hrvatska |
| Marketing Authorisation Holder | Jadran Galenski laboratorij d.d., Svilno 20, Rijeka, Hrvatska |
| Marketing Authorisation Date | 12.12.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/23-02/136 |
| Registration Number | 381-12-01/70-23-02 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | C09DX01 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
